Test Catalog

Test Id : SESPF

Sesame Seed, IgE, with Reflex to Sesame Seed Component, IgE, Serum

Useful For
Suggests clinical disorders or settings where the test may be helpful

Evaluating patients with suspected sesame seed allergy

Highlights

The determination of the relative amount of IgE antibody to total sesame seed, and IgE antibodies to specific sesame seed component, can aid in assessment of the potential strength and type of allergenic response to sesame seed.

 

IgE antibody to total sesame seed extract will be initially tested.

 

If total sesame seed IgE antibody is detectable (> or =0.10 kU/L), additional sesame seed component testing (Ses i 1) will be performed.

Reflex Tests
Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.

Test Id Reporting Name Available Separately Always Performed
SESPR Sesame Seed Component, IgE, S No No

Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

Testing begins with analysis of total sesame seed IgE. If the sesame seed total IgE result is negative (<0.10 kU/L), testing is complete.

 

If the sesame seed total IgE result is 0.10 kU/L or more, then sesame seed component (Ses i 1) testing will be performed at an additional charge.

Method Name
A short description of the method used to perform the test

Fluorescent Enzyme Immunoassay (FEIA)

NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test

Sesame Seed Component Reflex, S

Aliases
Lists additional common names for a test, as an aid in searching

Component testing

Sesame seed component

Ses i 1

Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

Testing begins with analysis of total sesame seed IgE. If the sesame seed total IgE result is negative (<0.10 kU/L), testing is complete.

 

If the sesame seed total IgE result is 0.10 kU/L or more, then sesame seed component (Ses i 1) testing will be performed at an additional charge.

Specimen Type
Describes the specimen type validated for testing

Serum

Ordering Guidance

For a listing of allergens available for testing, see Allergens - Immunoglobulin E (IgE) Antibodies

Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.6 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.

Special Instructions
Library of PDFs including pertinent information and forms related to the test

Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the Testing Laboratory

0.4 mL

Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK

Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
Frozen 90 days

Useful For
Suggests clinical disorders or settings where the test may be helpful

Evaluating patients with suspected sesame seed allergy

Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

Testing begins with analysis of total sesame seed IgE. If the sesame seed total IgE result is negative (<0.10 kU/L), testing is complete.

 

If the sesame seed total IgE result is 0.10 kU/L or more, then sesame seed component (Ses i 1) testing will be performed at an additional charge.

Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

De novo IgE sensitization to Sesamum indicum (sesame) seed and related products, such as sesame seed oil, can occur in both children and adults. In the United States, 0.21% of children and 0.24% of adults have reported convincing sesame allergy, but this varies around world. While sesame allergy is the ninth most common childhood food allergy in the United States, it is the third most common food allergy in Israel, with a prevalence of 0.93% in children. The allergy commonly lasts for life, with only 20% to 30% of children gaining tolerance to sesame seed. The median age onset for sesame allergy is 1 year. The use of whole sesame seed and its derivatives in food and health products is growing worldwide.

 

Sesame seed contains many components capable of eliciting an allergic response. A prospective multicenter European investigation suggests that sesame seed can cause allergic reactions that are more severe compared to other common seeds and nuts. In one study (n=16), 56% of patients developed urticaria while 38% presented with anaphylaxis after exposure to sesame seed. However, rhinitis and asthma have also been reported. Ses i 1 is the major allergenic component of sesame. 2S albumins, like Ses i 1, are extremely stable proteins, able to withstand temperatures up to 100 degrees C, acidic conditions, and pepsin digestion. Consequently, immunological exposure to these proteins is thought to occur directly in the gut, resulting in sensitization or an allergic response. Seven sesame seed components are registered by the joint World Health Organization/International Union of Immunological Societies Allergen Nomenclature Subcommittee including Ses i 1 and Ses i 2 (2S albumin proteins), Ses i 3 (7S vicilin-like globulin), Ses i 4 and Ses i 5 (oleosins), and Ses i 6 and Ses i 7 (11S globulins). Ses i 1 is the major allergenic component of sesame.

 

Of all sesame protein components, serum IgE antibodies against Ses i 1 are the most useful for diagnosis of sesame allergy. Measurement of IgE against Ses i 1 for the diagnosis of sesame allergy was shown to have a sensitivity and specificity of 86.1% and 85.7%, respectively, using a cutoff of 3.96 kUa/L. Comparatively, measure of IgE against sesame extract (cutoff of 7.97 kUa/L) had a similar sensitivity of 83.3%, but a much lower specificity of 48.2% due to known cross-reactivity with peanut and tree nuts/seeds. In the same study, it was shown that 92% of symptomatic patients were sensitized to Ses i 1, while only 32% of nonsymptomatic patients were sensitized.

 

Despite minor homology between 2S albumins, crossreactivity with other 2S albumin proteins still exists, such as those found in sesame seed, hazelnuts, peanuts, English walnuts, Brazil nuts, cashews, pistachios, poppyseed, or rapeseed. For example, Ses i 1 and Ses i 2 are related the peanut allergens Ara h 2, 6, and 7. Sesame seed allergy can coexist with peanut and tree nut allergies, and co-sensitization with these allergens, alongside kiwi and rye, have been reported. There is varying prevalence of sesame seed and tree nut/peanut related allergy coexistence. Sesame seed allergy coexists with 15% to 54% of self-reported peanut allergies, 8% to 14.8% of tree nut allergies, and 50% to 54% of patients who have both tree nut and peanut allergies.

Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Class

IgE kU/L

Interpretation

0

<0.10

Negative

0/1

0.10-0.34

Borderline/equivocal

1

0.35-0.69

Equivocal

2

0.70-3.49

Positive

3

3.50-17.4

Positive

4

17.5-49.9

Strongly positive

5

50.0-99.9

Strongly positive

6

> or =100

Strongly positive

Concentrations of 0.70 kU/L or more (class 2 and above) will flag as abnormally high.

Reference values apply to all ages.

Interpretation
Provides information to assist in interpretation of the test results

If the total serum IgE antibody against sesame seed is detectable (> or =0.10 IgE kUa/L), it is possible the patient has been sensitized to the components of sesame seed or other potential substances with cross activity. An additional test utilizing Ses i 1, a specific allergenic sesame seed component IgE antibody, will be performed to further confirm sensitization to sesame seed.

 

If the total serum IgE antibody against sesame seed is negative (<0.10 IgE kUa/L), the patient lacks detectable sensitization to sesame seed components. A report will be provided without additional testing performed. An oral food challenge may be helpful in the diagnosis of sesame seed allergy.

Cautions
Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Positive results for IgE antibody against total sesame seed IgE or specific component IgE indicate the sensitization to sesame seed or cross-reactive allergen only. Cross-reactivity and co-sensitization have been documented between allergens in sesame seed and various other foods, including, but not limited to, peanuts, hazelnuts, walnuts, black walnuts, cashews, macadamia nuts, pistachios, kiwis, rye, and poppy seeds. A positive result cannot be exclusively used for diagnosis of sesame seed-related allergy.

 

Negative results of total antibody against sesame seed IgE or sesame seed specific IgE antibody components only suggest the absence of sensitization to potential allergenic components of sesame seeds. A negative result does not exclude the possibility of allergy to sesame seeds.

 

IgE antibody testing may not offer useful results in patients previously treated with immunotherapy to ascertain residual clinical sensitivity or in cases where the medical management does not rely on the identification of allergen specificity.

 

False-positive results for IgE antibodies may manifest in patients with significantly elevated serum IgE levels (>2500 kU/L) due to nonspecific binding to allergen solid phases.

Clinical Reference
Recommendations for in-depth reading of a clinical nature

1. Dalal I, Goldberg M, Katz Y. Sesame seed food allergy. Curr Allergy Asthma Rep. 2012;12(4):339-345

2. Warren CM, Chadha AS, Sicherer SH, et al. Prevalence and severity of sesame allergy in the United States. JAMA network open. 2019;2(8):e199144-e199144

3. Sokol K, Rasooly M, Dempsey C, et al. Prevalence and diagnosis of sesame allergy in children with IgE-mediated food allergy. Pediatr Allergy Immunol. 2020;31(2):214-218

4. Adatia A, Clarke AE, Yanishevsky Y, Ben-Shoshan M. Sesame allergy: current perspectives. J Asthma Allergy. 2017;10:141-151.

5. Cohen A, Goldberg M, Levy B, Leshno M, Katz Y. Sesame food allergy and sensitization in children: the natural history and long-term follow-up. Pediatr Allergy Immunol. 2007;18(3):217-223

6. Gupta RS, Lau CH, Sita EE, Smith B, Greenhawt M. Factors associated with reported food allergy tolerance among US children. Ann Allergy Asthma Immunol. 2013;111(3):194-198

7. Ziegler JB, Aalberse RC. Sesame: an increasingly popular word and common food allergen. J Allergy Clin Immunol: Pract. 2020;8(5):1689-1691

8. U.S. Food and Drug Administration. Allergic to Sesame? Food Labels Now Must List Sesame as an Allergen. Updated January 10, 2023. Accessed March 3, 2024.Available at //www.fda.gov/consumers/consumer-updates/allergic-sesame-food-labels-now-must-list-sesame-allergen

9. WHO/IUIS Allergen Nomenclature Sub-Committee. Sesamum indicum - All Allergen. Accessed March 3, 2024.Available at www.allergen.org/search.php?allergensource=Sesamum+indicum

10. Pastorello EA, Varin E, Farioli L, et al. The major allergen of sesame seeds (Sesamum indicum) is a 2S albumin. J Chromatogr B Biomed Sci Appl. 2001;756(1-2):85-93

11. Moreno FJ, Clemente A. 2S albumin storage proteins: what makes them food allergens?. Open Biochem J. 2008;2:16-28

12. Maruyama N, Nakagawa T, Ito K, et al. Measurement of specific IgE antibodies to Ses i 1 improves the diagnosis of sesame allergy. Clin Exp Allergy. 2016;46(1):163-171

13. Dreskin SC, Koppelman SJ, Andorf S, et al. The importance of the 2S albumins for allergenicity and cross-reactivity of peanuts, tree nuts, and sesame seeds. J Allergy Clin Immunol. 2021;147(4):1154-1163

14. Brough HA, Caubet JC, Mazon A, et al. Defining challenge-proven coexistent nut and sesame seed allergy: a prospective multicenter European study. J Allergy Clin Immunol. 2020;145(4):1231-1239

15. Tuano KTS, Dillard KH, Guffey D, Guffey D, Davis CM. Development of sesame tolerance and cosensitization of sesame allergy with peanut and tree nut allergy in children. Ann Allergy. 2016;117(6):708-710

16. Yanagida N, Ejiri Y, Takeishi D, et al. Ses i 1-specific IgE and sesame oral food challenge results. J Allergy Clin Immunol Pract. 2019;7(6):2084-2086

17. Saf S, Sifers TM, Baker MG et al. Diagnosis of Sesame Allergy: Analysis of Current Practice and Exploration of Sesame Component Ses i 1. J Allergy Clin Immunol Pract. 2020;8(5):1681-1688

18. Sato S, Yanagida N, Ebisawa M. How to diagnose food allergy. Curr Opin Allergy Clin Immunol. 2018;18(3):214-221

19. Foong RX, Dantzer JA, Wood RA, Santos AF. Improving Diagnostic Accuracy in Food Allergy. J Allergy Clin Immunol Pract. 2021;9(1):71-80

20. Patel A, Bahna SL. Hypersensitivities to sesame and other common edible seeds. Allergy. 2016;71(10):1405-1413

21. Segal L, Ben-Shoshan M, Alizadehfar R, et al. Initial and accidental reactions are managed inadequately in children with sesame allergy. J Allergy Clin Immunol Pract. 2017;5(2):482-485

Method Description
Describes how the test is performed and provides a method-specific reference

Specific IgE from the patient's serum reacts with the allergen of interest, which is covalently coupled to an ImmunoCAP. After washing away nonspecific IgE, enzyme-labeled anti-IgE antibody is added to form a complex. After incubation, unbound anti-IgE is washed away, and the bound complex is incubated with a developing agent. After stopping the reaction, the fluorescence of the eluate is measured. Fluorescence is proportional to the amount of specific IgE present in the patient's sample (ie, the higher the fluorescence value, the more IgE antibody is present).(Package insert: ImmunoCAP System Specific IgE FEIA. Phadia AB; Rev 06/2020)

PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information

No

Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.

Monday through Friday

Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.

Same day/1 to 3 days

Specimen Retention Time
Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

14 days

Performing Laboratory Location
Indicates the location of the laboratory that performs the test

Rochester

Fees
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.

  • Authorized users can sign in to Test Prices for detailed fee information.
  • Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
  • Prospective clients should contact their account representative. For assistance, contact Customer Service.

Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

CPT codes are provided by the performing laboratory.

86003

LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.

Test Id Test Order Name Order LOINC Value
SESPF Sesame Seed Component Reflex, S 6242-2
Result Id Test Result Name Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
SESA1 Sesame Seed, IgE, S 6242-2

Test Setup Resources

Setup Files
Test setup information contains test file definition details to support order and result interfacing between Mayo Clinic Laboratories and your Laboratory Information System.

Excel | PHP Pdf | CMS Pdf

Sample Reports
Normal and Abnormal sample reports are provided as references for report appearance.

Normal Reports | Abnormal Reports

SI Sample Reports
International System (SI) of Unit reports are provided for a limited number of tests. These reports are intended for international account use and are only available through MayoLINK accounts that have been defined to receive them.

SI Normal Reports | SI Abnormal Reports